Natco Pharma Ltd has informed BSE regarding a Press Release dated November 24, 2016 titled 'Natco Receives Final approval for generic Budesonide Capsules, 3 mg, for USA market'.
Ask Value Research 
News Announcement
Natco Pharma: Natco Receives Final approval for generic Budesonide Capsules, 3 mg, for USA market
24-Nov-2016
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
